Table 1 Patient and clinical characteristics*
From: Fall predictors in older cancer patients: a multicenter prospective study
Age, years (median (range) (n = 937) | 76 (70 – 95) | ||||
|---|---|---|---|---|---|
| Â | n | % | 95% CI | ||
Gender (n = 937) | - Female |  | 595 | 63.5 | 60.4-66.6 |
- Male | 342 | 36.5 | 33.4-39.6 | ||
Tumor type (n = 937) | - Carcinoma | - Breast | 379 | 40.4 | 37.3-43.6 |
- Colorectal | 193 | 20.6 | 18.0-23.2 | ||
- Lung | 73 | 7.8 | 6.1-9.5 | ||
- Ovarian | 59 | 6.3 | 4.7-7.9 | ||
- Prostate | 84 | 9.0 | 7.1-10.8 | ||
- Hematological malignancies | Â | 149 | 15.9 | 13.6-18.2 | |
Timepoint of assessment (n = 937) | - New diagnosis |  | 572 | 61.0 | 57.9-64.2 |
- Disease progression/relapse | 365 | 39.0 | 35.8-42.1 | ||
Carcinoma (n = 788) | - Stage | - I-III | 380 | 48.2 | 44.7-51.7 |
- IV | 408 | 51.8 | 48.2-55.3 | ||
Hematological malignancies (n = 149) | - Setting | - Curative | 48 | 32.2 | 24.7-39.7 |
- Palliative | 101 | 67.8 | 60.3-75.3 | ||
Comorbidities | CCI (0–37) (n = 937) | - No comorbidities: score 0 | 432 | 46.1 | 42.9-49.3 |
- Comorbidity score 1 | 232 | 24.8 | 22.0-27.5 | ||
- Comorbidity score ≥ 2 | 273 | 29.1 | 26.2-32.0 | ||
Pain | VAS (0–10) (n = 936) | - No pain: score 0 | 467 | 49.9 | 46.7-53.1 |
- Mild pain: score 1 – 3 | 144 | 15.4 | 13.1-17.7 | ||
- Pain to treat: score ≥ 4 | 325 | 34.7 | 31.7-37.8 | ||
Performance status | ECOG-PS (0–5) (n = 936) | - Score 0-1 | 677 | 72.3 | 69.5-75.2 |
- Score 2-4 | 259 | 27.7 | 27.3-33.1 | ||
Polypharmacy (n = 910) | - 0-4 different drugs | 427 | 46.9 | 43.7-50.2 | |
|  |  | - ≥5 different drugs | 483 | 53.1 | 49.8-56.3 |